Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antigen-primed donor memory lymphocyte infusion for viral immunity after HSCT
NCT05066958Phase 2Unknown
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 2, open-label trial in cytomegalovirus infection (CMV), Epstein-Barr virus infection, adenovirus infection and 1 more, sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Primary endpoint: acute Graft Versus Host Disease at 100 days. Status: unknown.
02
Conditions
cytomegalovirus infection (CMV)Epstein-Barr virus infectionadenovirus infectionBK virus infection
Beyond the preview
Go deeper on NCT05066958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066958.